Dehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period

Autor(es)

Teixeira, Caio Jordao ^{[1, 2]} ; Veras, Katherine ^[3] ; de Oliveira Carvalho, Carla Roberta ^[1]

Afiliação do(s) autor(es)

^[1] Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, 1524 Prof Lineu Prestes Ave, ICB 1, BR-05508900 Sao Paulo, SP - Brazil

^[2] Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, 105 Alexander Fleming St, BR-13083881 Campinas, SP - Brazil

^[3] Univ Mogi das Cruzes, Dept Nutr, 200 Dr Candido XA Souza Ave, BR-08780911 Sao Paulo, SP - Brazil

• Tipo de documento: Artigo de Revisão
• Fonte: JOURNAL OF MOLECULAR MEDICINE-JMM; NOV 2019.
• Citações Web of Science: 0

Resumo

Dehydroepiandrosterone (DHEA), mostly present as its sulfated ester (DHEA-S), is an anabolic hormone that naturally declines with age. Furthermore, it is the most abundant androgen and estrogen precursor in humans. Low plasma levels of DHEA have been strongly associated with obesity, insulin resistance, dyslipidemia, and high blood pressure, increasing the risk of cardiovascular disease. In this respect, DHEA could be regarded as a promising agent against metabolic syndrome (MetS) in postmenopausal women, since several age-related metabolic diseases are reported during aging. There are plenty of experimental evidences showing beneficial effects after DHEA therapy on carbohydrate and lipid metabolism, as well as cardiovascular health. However, its potential as a therapeutic agent appears to attract controversy, due to the lack of effects on some symptoms related to MetS. In this review, we examine the available literature regarding the impact of DHEA therapy on adiposity, glucose metabolism, and the cardiovascular system in the postmenopausal period. Both clinical studies and in vitro and in vivo experimental models were selected, and where possible, the main cellular mechanisms involved in DHEA therapy were discussed. (AU)

• Processo FAPESP: 12/14183-7 - Efeito da suplementação com DHEA em coração de ratas com hipertensão arterial induzida por castração e dieta hiperlipídica
• Beneficiário: Caio Jordão Teixeira
• Modalidade de apoio: Bolsas no Brasil - Mestrado